Author
Listed:
- Eduard Schulz
(Medical University of Graz)
- Petra Klampfl
(Medical University of Graz
General Hospital Graz West)
- Stefanie Holzapfel
(Institute of Human Genetics, Faculty of Medicine, University of Bonn)
- Andreas R. Janecke
(Molecular and Clinical Pharmacology, Medical University of Innsbruck
Medical University of Innsbruck)
- Peter Ulz
(Institute of Human Genetics, Medical University of Graz)
- Wilfried Renner
(Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz)
- Karl Kashofer
(Institute of Pathology, Medical University of Graz)
- Satoshi Nojima
(WPI Immunology Frontier Research Center, Osaka University
Osaka University Graduate School of Medicine, Osaka University)
- Anita Leitner
(Nose and Throat, Medical University of Graz)
- Armin Zebisch
(Medical University of Graz)
- Albert Wölfler
(Medical University of Graz)
- Sybille Hofer
(Medical University of Graz)
- Armin Gerger
(Medical University of Graz)
- Sigurd Lax
(General Hospital Graz West)
- Christine Beham-Schmid
(Institute of Pathology, Medical University of Graz)
- Verena Steinke
(Institute of Human Genetics, Faculty of Medicine, University of Bonn)
- Ellen Heitzer
(Institute of Human Genetics, Medical University of Graz)
- Jochen B. Geigl
(Institute of Human Genetics, Medical University of Graz)
- Christian Windpassinger
(Institute of Human Genetics, Medical University of Graz)
- Gerald Hoefler
(Institute of Pathology, Medical University of Graz)
- Michael R. Speicher
(Institute of Human Genetics, Medical University of Graz)
- C. Richard Boland
(Baylor University Medical Center)
- Atsushi Kumanogoh
(WPI Immunology Frontier Research Center, Osaka University
Allergy and Rheumatic Disease, Graduate School of Medicine, Osaka University
JST, CREST)
- Heinz Sill
(Medical University of Graz)
Abstract
Familial colorectal cancer type X (FCCTX) is characterized by clinical features of hereditary non-polyposis colorectal cancer with a yet undefined genetic background. Here we identify the SEMA4A p.Val78Met germline mutation in an Austrian kindred with FCCTX, using an integrative genomics strategy. Compared with wild-type protein, SEMA4AV78M demonstrates significantly increased MAPK/Erk and PI3K/Akt signalling as well as cell cycle progression of SEMA4A-deficient HCT-116 colorectal cancer cells. In a cohort of 53 patients with FCCTX, we depict two further SEMA4A mutations, p.Gly484Ala and p.Ser326Phe and the single-nucleotide polymorphism (SNP) p.Pro682Ser. This SNP is highly associated with the FCCTX phenotype exhibiting increased risk for colorectal cancer (OR 6.79, 95% CI 2.63 to 17.52). Our study shows previously unidentified germline variants in SEMA4A predisposing to FCCTX, which has implications for surveillance strategies of patients and their families.
Suggested Citation
Eduard Schulz & Petra Klampfl & Stefanie Holzapfel & Andreas R. Janecke & Peter Ulz & Wilfried Renner & Karl Kashofer & Satoshi Nojima & Anita Leitner & Armin Zebisch & Albert Wölfler & Sybille Hofer , 2014.
"Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X,"
Nature Communications, Nature, vol. 5(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6191
DOI: 10.1038/ncomms6191
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6191. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.